Operating Lease, Right-of-Use Asset in USD of Cullinan Therapeutics, Inc. from Q4 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cullinan Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2021 to Q3 2025.
  • Cullinan Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1.05M, a 48.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Cullinan Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.05M -$973K -48.2% 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 $1.18M -$941K -44.4% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $1.55M -$786K -33.6% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $1.67M -$876K -34.4% 31 Dec 2024 10-Q 06 Nov 2025
Q3 2024 $2.02M -$906K -31% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $2.12M -$1.38M -39.4% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $2.34M -$1.48M -38.8% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $2.54M -$1.59M -38.4% 31 Dec 2023 10-K 27 Feb 2025
Q3 2023 $2.93M -$1.57M -34.9% 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 $3.5M +$2.43M +226% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $3.82M +$2.63M +220% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $4.13M +$4.13M 31 Dec 2022 10-K 14 Mar 2024
Q3 2022 $4.5M 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $1.07M 30 Jun 2022 10-Q 10 Aug 2022
Q1 2022 $1.19M 31 Mar 2022 10-Q 16 May 2022
Q4 2021 $0 31 Dec 2021 10-K 09 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.